Paul R. Fonteyne Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

AMLX Quotes by TradingView

Paul R. Fonteyne is of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 3,947 shares of AMLX, which is worth approximately $19,577. The most recent transaction as insider was on Jan 06, 2022, when has been sold 3,947 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $74,993. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.95K
0% 3M change
0% 12M change
Total Value Held $19,577

PAUL R. FONTEYNE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2022
BUY
Open market or private purchase
$74,993 $19.0 p/Share
3,947 Added 50.0%
3,947 Common Stock

Also insider at

AMAG
AMAG PHARMACEUTICALS, INC.
Director
APLS
Apellis Pharmaceuticals, Inc. Healthcare
Director
CVET
COVETRUS, INC. Healthcare
Director
GLS
GELESIS HOLDINGS, INC. Healthcare
Director
PRF

Paul R. Fonteyne

Portland, ME

Track Institutional and Insider Activities on AMLX

Follow Amylyx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMLX